Skip to main content
Premium Trial:

Request an Annual Quote

Konstantinos Andrikopoulos, Eric Olson

Premium
RXi Pharmaceuticals has named Konstantinos Andrikopoulos as vice president, legal counsel, and chief intellectual property officer.
 
Andrikopoulos was previously senior patent counsel for Shire Human Genetic Therapies. Before his time at Shire, he worked as a technology specialist, patent agent, and patent attorney for Wolf, Greenfield, and Sacks.
 
He holds a JD from Suffolk University Law School, a PhD in biomedical sciences from the City University of New York, and a BSc in biophysics from the University of East London.
 

 
Miragen Therapeutics said last week that its CSO and co-founder, Eric Olson, was awarded the American Heart Association National Research Achievement Award.
 
Olson is also a professor and chairman of the molecular biology department at the University of Texas Southwestern Medical Center. The award was given to him for his work in identifying molecular mechanisms that control normal and abnormal growth and development of the heart and cardiovascular system, Miragen said.

The Scan

Unwrapping Mummies' Faces

LiveScience reports that Parabon NanoLabs researchers have reconstructed how three Egyptian mummies may have looked.

Study on Hold

The Spectrum 10K study has been put on hold due to a backlash, leading the researchers to conduct consultations with the autism community, Nature News reports.

Others Out There Already

Reuters reports that Sanofi is no longer developing an mRNA-based vaccine for SARS-CoV-2.

PNAS Papers on GWAS False Discovery, PRAMEF2 Role in Tumorigenesis, RNA Virus Reverse Genetics

In PNAS this week: strategy to account for GWAS false-discovery rates, role of PRAMEF2 in cancer development, and more.